Home » Stocks » CHX

ChampionX Corporation (CHX)

Stock Price: $17.71 USD 0.02 (0.11%)
Updated Jan 19, 2021 4:00 PM EST - Market closed
Market Cap 3.54B
Revenue (ttm) 1.44B
Net Income (ttm) -755.41M
Shares Out 199.81M
EPS (ttm) -9.23
PE Ratio n/a
Forward PE 31.45
Dividend n/a
Dividend Yield n/a
Trading Day January 19
Last Price $17.71
Previous Close $17.69
Change ($) 0.02
Change (%) 0.11%
Day's Open 18.01
Day's Range 17.47 - 18.02
Day's Volume 1,152,496
52-Week Range 3.02 - 30.09

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
GlobeNewsWire - 4 days ago

THE WOODLANDS, Texas, Jan. 15, 2021 (GLOBE NEWSWIRE) -- ChampionX Corporation (“ChampionX” or the “Company”) (NASDAQ: CHX) announced today that it will release its fourth quarter and full year...

Zacks Investment Research - 3 weeks ago

As of late, it has definitely been a great time to be an investor of ChampionX Corporation (CHX).

Zacks Investment Research - 4 weeks ago

With only eight trading days left this year, markets are bracing for the so-called Santa Claus rally.

Other stocks mentioned: ADNT, CVGI, MIK, RYAM
GlobeNewsWire - 4 weeks ago

Ticker symbol will remain “CHX” Ticker symbol will remain “CHX”

Zacks Investment Research - 1 month ago

ChampionX Corporation (CHX) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.

24/7 Wall Street - 1 month ago

Many reflections need to be considered as 2020 fades away and 2021 approaches. The COVID-19 pandemic's deaths and illnesses are the top story, without question.

Other stocks mentioned: LNG, MNST, RUN, TJX, VNOM, VAC
GlobeNewsWire - 1 month ago

THE WOODLANDS, Texas, Nov. 30, 2020 (GLOBE NEWSWIRE) -- ChampionX Corporation (NYSE: CHX) (the “Company” or “ChampionX”) announced today the commencement of a cash tender offer (the “Tender Of...

GlobeNewsWire - 2 months ago

THE WOODLANDS, Texas, Nov. 16, 2020 (GLOBE NEWSWIRE) -- ChampionX Corporation (“ChampionX”) (NYSE: CHX) announced today an exclusive collaboration agreement with Modumetal Inc. The agreement i...

Seeking Alpha - 2 months ago

ChampionX's (CHX) CEO Soma Somasundaram on Q3 2020 Results - Earnings Call Transcript

Zacks Investment Research - 2 months ago

ChampionX (CHX) delivered earnings and revenue surprises of 142.86% and 0.31%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

GlobeNewsWire - 2 months ago

THE WOODLANDS, Texas, Oct. 28, 2020 (GLOBE NEWSWIRE) -- ChampionX Corporation (“ChampionX”) (NYSE: CHX) (“the Company”) today announced third quarter of 2020 results, our first full quarter fo...

Zacks Investment Research - 2 months ago

ChampionX (CHX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

About CHX

ChampionX Corporation provides chemistry solutions, and engineered equipment and technologies that help companies to drill for and produce oil and gas worldwide. It offers chemistry solutions to enhance production from flowing oil and gas wells, as well as for drilling and completion activities. The company also provides production and automation technologies, including artificial lift equipment and solutions, such as rod pumping systems, electric submersible pump systems, progressive cavity pumps, and drive systems and plunger lifts; and autom... [Read more...]

Industry
Oil & Gas Equipment & Services
CEO
Sivasankaran Somasundaram
Employees
3,000
Stock Exchange
NASDAQ
Ticker Symbol
CHX
Full Company Profile

Financial Performance

In 2019, ChampionX's revenue was $1.13 billion, a decrease of -7.13% compared to the previous year's $1.22 billion. Earnings were $52.16 million, a decrease of -43.75%.

Financial Statements

Analyst Forecasts

According to 11 analysts, the average rating for ChampionX stock is "Buy." The 12-month stock price forecast is 18.43, which is an increase of 4.07% from the latest price.

Price Target
$18.43
(4.07% upside)
Analyst Consensus: Buy